InteKrin Therapeutics
Latest round
- Series C
Last raised
- Aug 2008
Total raised
- $42M
Investors
- 8
About InteKrin Therapeutics
InteKrin Therapeutics is based in US and operates as a clinical stage bio-pharmaceutical company.
Who invested in InteKrin Therapeutics
8 investors across 2 rounds
See all investors in InteKrin Therapeutics
Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.
Questions about InteKrin Therapeutics
Who invested in InteKrin Therapeutics?
InteKrin Therapeutics has 8 investors on record across 2 venture rounds. Sign up free to see every VC on the cap table and the rounds they joined.
How much funding has InteKrin Therapeutics raised?
InteKrin Therapeutics has raised 2 venture rounds. Sign up free to see how much each round raised and the total.
When did InteKrin Therapeutics last raise money?
InteKrin Therapeutics's most recent round on record is a Series C, in Aug 2008.
What does InteKrin Therapeutics do?
InteKrin Therapeutics is based in US and operates as a clinical stage bio-pharmaceutical company.
Where is InteKrin Therapeutics headquartered?
InteKrin Therapeutics is headquartered in Los Altos, US.
Which VCs invest in companies like InteKrin Therapeutics?
Among active investors with capital left to deploy, Andreessen Horowitz, Founders Fund, Accel and Thrive Capital back biotechnology companies at InteKrin Therapeutics's stage. Their profiles are linked below.
VCs backing biotechnology startups at Series C
Raising like InteKrin Therapeutics? Find the right VCs.
Capital Atlas matches your startup to active investors by stage, sector and region.